STATE STREET CORP - IDERA PHARMACEUTICALS INC ownership

IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K405. A total of 42 filers reported holding IDERA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of IDERA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$76,820
+87.4%
219,488
+100.0%
0.00%
Q3 2022$41,000
-18.0%
109,7440.0%0.00%
Q2 2022$50,000
-9.1%
109,7440.0%0.00%
Q1 2022$55,000
-12.7%
109,7440.0%0.00%
Q4 2021$63,000
-44.2%
109,7440.0%0.00%
Q3 2021$113,000
-14.4%
109,7440.0%0.00%
Q2 2021$132,000
+388.9%
109,744
+437.7%
0.00%
Q1 2021$27,000
-60.3%
20,410
+10.9%
0.00%
Q4 2020$68,000
+74.4%
18,4100.0%0.00%
Q3 2020$39,000
-7.1%
18,410
-20.7%
0.00%
Q2 2020$42,000
+35.5%
23,2120.0%0.00%
Q1 2020$31,000
-26.2%
23,2120.0%0.00%
Q4 2019$42,000
-46.8%
23,212
-14.7%
0.00%
Q3 2019$79,000
+2.6%
27,212
-5.4%
0.00%
Q2 2019$77,000
-92.1%
28,774
-92.5%
0.00%
Q1 2019$979,000
-17.1%
383,988
-9.9%
0.00%
Q4 2018$1,181,000
-62.5%
426,217
+20.6%
0.00%
Q3 2018$3,149,000353,3790.00%
Other shareholders
IDERA PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
ABG Innovation Capital Partners III GP Ltd 56,250$206,0000.12%
Baker Brothers Advisors 4,608,786$16,914,0000.06%
Artal Group S.A. 500,000$1,835,0000.04%
HOLLENCREST CAPITAL MANAGEMENT 90,000$331,0000.04%
Spotlight Asset Group, Inc. 21,500$79,0000.03%
DCF Advisers, LLC 18,755$69,0000.03%
683 Capital Management, LLC 88,470$325,0000.02%
Palo Alto Investors LP 77,044$283,0000.02%
Alpine Global Management, LLC 13,966$51,0000.01%
TCI Wealth Advisors, Inc. 4,000$15,0000.01%
View complete list of IDERA PHARMACEUTICALS INC shareholders